OIC New Materials Corporation

OIC New Materials has developed a proprietary two-layer micelle nano-emulsion technology that encapsulates poorly-absorbed active compounds (such as curcumin) into nano-scale particles, significantly improving bioavailability compared to conventional formulations. The R&D process involved years of iterative experimentation to achieve consistent particle size distribution, a key technical challenge in nano-drug delivery.

As a certified science and technology enterprise since 2016, OIC represents an independent Vietnamese deep-tech success story in pharmaceutical nanotechnology, an area where the country previously relied almost entirely on imported formulation technology.

1. Two-layer micelle nano-emulsion technology
2. Improved bioavailability for poorly-absorbed compounds
3. Consistent nano-particle size control
4. Domestic pharmaceutical formulation R&D
5. Intellectual property/patent-backed process
6. Technology licensing capability